808 related articles for article (PubMed ID: 19285915)
1. Resistance to antimalarial compounds: methods and applications.
Witkowski B; Berry A; Benoit-Vical F
Drug Resist Updat; 2009; 12(1-2):42-50. PubMed ID: 19285915
[TBL] [Abstract][Full Text] [Related]
2. [For new antimalarial drugs: the methods of fundamental research].
Ambroise-Thomas P
Med Trop (Mars); 1995; 55(4 Suppl):23-6. PubMed ID: 8649261
[TBL] [Abstract][Full Text] [Related]
3. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
[TBL] [Abstract][Full Text] [Related]
4. Malaria chemotherapeutics part I: History of antimalarial drug development, currently used therapeutics, and drugs in clinical development.
Schlitzer M
ChemMedChem; 2007 Jul; 2(7):944-86. PubMed ID: 17530725
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in antimalarial drug development.
Vangapandu S; Jain M; Kaur K; Patil P; Patel SR; Jain R
Med Res Rev; 2007 Jan; 27(1):65-107. PubMed ID: 16700012
[TBL] [Abstract][Full Text] [Related]
6. Novel molecular targets for antimalarial chemotherapy.
Jana S; Paliwal J
Int J Antimicrob Agents; 2007 Jul; 30(1):4-10. PubMed ID: 17339102
[TBL] [Abstract][Full Text] [Related]
7. The origins of antimalarial drug resistance.
Hastings IM
Trends Parasitol; 2004 Nov; 20(11):512-8. PubMed ID: 15471702
[TBL] [Abstract][Full Text] [Related]
8. Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development.
Na-Bangchang K; Karbwang J
Fundam Clin Pharmacol; 2009 Aug; 23(4):387-409. PubMed ID: 19709319
[TBL] [Abstract][Full Text] [Related]
9. Antimalarial drugs inhibiting hemozoin (beta-hematin) formation: a mechanistic update.
Kumar S; Guha M; Choubey V; Maity P; Bandyopadhyay U
Life Sci; 2007 Feb; 80(9):813-28. PubMed ID: 17157328
[TBL] [Abstract][Full Text] [Related]
10. Antimalarial drugs - host targets (re)visited.
Cunha-Rodrigues M; Prudêncio M; Mota MM; Haas W
Biotechnol J; 2006 Mar; 1(3):321-32. PubMed ID: 16897712
[TBL] [Abstract][Full Text] [Related]
11. [Malaria prophylaxis and treatment: problems, recent developments and perspectives].
Pradines B; Vial H; Olliaro P
Med Trop (Mars); 2003; 63(1):79-98. PubMed ID: 12891756
[TBL] [Abstract][Full Text] [Related]
12. Recent developments in research on terrestrial plants used for the treatment of malaria.
Wright CW
Nat Prod Rep; 2010 Jul; 27(7):961-8. PubMed ID: 20532364
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of new antimalarial agents from 4-aminoquinoline.
Solomon VR; Puri SK; Srivastava K; Katti SB
Bioorg Med Chem; 2005 Mar; 13(6):2157-65. PubMed ID: 15727868
[TBL] [Abstract][Full Text] [Related]
14. New chimeric antimalarials with 4-aminoquinoline moiety linked to a tetraoxane skeleton.
Opsenica I; Opsenica D; Lanteri CA; Anova L; Milhous WK; Smith KS; Solaja BA
J Med Chem; 2008 Oct; 51(19):6216-9. PubMed ID: 18774792
[TBL] [Abstract][Full Text] [Related]
15. The phenothiazinium chromophore and the evolution of antimalarial drugs.
Wainwright M; Amaral L
Trop Med Int Health; 2005 Jun; 10(6):501-11. PubMed ID: 15941412
[TBL] [Abstract][Full Text] [Related]
16. The design of original antimalarial drugs. An example of phospholipid metabolism.
Vial HJ; Ancelin ML; Elabbadi N; Gumila C; Bonnet H; Jeong YH; Philippot J; Calas M; Portefaix P; Piquet G
Parassitologia; 1993 Jul; 35 Suppl():125-7. PubMed ID: 8233602
[TBL] [Abstract][Full Text] [Related]
17. [Role of modulators in Plasmodium falciparum resistance to antimalarials].
Verdier F; Pussard E
Med Trop (Mars); 1995; 55(4 Suppl):27-32. PubMed ID: 8649262
[TBL] [Abstract][Full Text] [Related]
18. Impaired fitness of drug-resistant malaria parasites: evidence and implication on drug-deployment policies.
Babiker HA; Hastings IM; Swedberg G
Expert Rev Anti Infect Ther; 2009 Jun; 7(5):581-93. PubMed ID: 19485798
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and structure-activity relationship studies of 4-quinolinyl- and 9-acrydinylhydrazones as potent antimalarial agents.
Fattorusso C; Campiani G; Kukreja G; Persico M; Butini S; Romano MP; Altarelli M; Ros S; Brindisi M; Savini L; Novellino E; Nacci V; Fattorusso E; Parapini S; Basilico N; Taramelli D; Yardley V; Croft S; Borriello M; Gemma S
J Med Chem; 2008 Mar; 51(5):1333-43. PubMed ID: 18278859
[TBL] [Abstract][Full Text] [Related]
20. Exploration of 4(1H)-pyridones as a novel family of potent antimalarial inhibitors of the plasmodial cytochrome bc1.
Bueno JM; Herreros E; Angulo-Barturen I; Ferrer S; Fiandor JM; Gamo FJ; Gargallo-Viola D; Derimanov G
Future Med Chem; 2012 Dec; 4(18):2311-23. PubMed ID: 23234553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
